Theriva Biologics, Inc.
TOVX
$1.42
$0.00780.55%
AMEX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -4.45M | -7.73M | -8.32M | -5.17M | -5.49M |
| Total Depreciation and Amortization | 27.00K | 33.00K | 38.00K | 39.00K | 39.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 245.00K | 3.53M | 3.84M | 247.00K | -1.57M |
| Change in Net Operating Assets | -516.00K | 253.00K | 991.00K | -2.00K | 471.00K |
| Cash from Operations | -4.69M | -3.91M | -3.45M | -4.88M | -6.54M |
| Capital Expenditure | 0.00 | 0.00 | -1.00K | -- | -56.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 0.00 | 0.00 | -1.00K | -- | -56.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00 | 0.00 | -67.00K | -- | 0.00 |
| Issuance of Common Stock | 7.00K | 3.72M | 1.84M | -- | 62.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -1.52M |
| Cash from Financing | 7.00K | 3.72M | 1.77M | -- | -1.46M |
| Foreign Exchange rate Adjustments | -123.00K | 17.00K | 12.00K | -38.00K | 76.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -4.81M | -180.00K | -1.67M | -4.92M | -7.98M |